908 related articles for article (PubMed ID: 31388093)
1. The intestinal microbiota fuelling metabolic inflammation.
Tilg H; Zmora N; Adolph TE; Elinav E
Nat Rev Immunol; 2020 Jan; 20(1):40-54. PubMed ID: 31388093
[TBL] [Abstract][Full Text] [Related]
2. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
3. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
Front Immunol; 2020; 11():571731. PubMed ID: 33178196
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
[TBL] [Abstract][Full Text] [Related]
6. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
[TBL] [Abstract][Full Text] [Related]
8. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis.
Bellenger J; Bellenger S; Escoula Q; Bidu C; Narce M
Biochimie; 2019 Apr; 159():66-71. PubMed ID: 30690133
[TBL] [Abstract][Full Text] [Related]
9. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota and the immune system in metabolic diseases.
Sittipo P; Lobionda S; Lee YK; Maynard CL
J Microbiol; 2018 Mar; 56(3):154-162. PubMed ID: 29492872
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiota: a key regulator of metabolic diseases.
Yang JY; Kweon MN
BMB Rep; 2016 Oct; 49(10):536-541. PubMed ID: 27530685
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, obesity and metabolic disorders.
Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
[TBL] [Abstract][Full Text] [Related]
14. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
Mavilio M; Marchetti V; Fabrizi M; Stöhr R; Marino A; Casagrande V; Fiorentino L; Cardellini M; Kappel B; Monteleone I; Garret C; Mauriello A; Monteleone G; Farcomeni A; Burcelin R; Menghini R; Federici M
Cell Rep; 2016 Jul; 16(3):731-43. PubMed ID: 27373162
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Chakaroun RM; Massier L; Kovacs P
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32295104
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome, endocrine control of gut barrier function and metabolic diseases.
Régnier M; Van Hul M; Knauf C; Cani PD
J Endocrinol; 2021 Feb; 248(2):R67-R82. PubMed ID: 33295880
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases.
Hyun CK
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502047
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
Wei YX; Zheng KY; Wang YG
World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
[TBL] [Abstract][Full Text] [Related]
19. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
Wisniewski PJ; Dowden RA; Campbell SC
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications.
Potrykus M; Czaja-Stolc S; Stankiewicz M; Kaska Ł; Małgorzewicz S
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
